Thanks to undercover videos released by an anti-abortion group, Planned Parenthood is once again the focus of public and media attention. This situation has brought up many moral issues that are well worth considering.
One matter of concern is the claim that Planned Parenthood has engaged in selling aborted fetuses for profit. The edited videos certainly seem crafted to create the impression that Planned Parenthood was haggling over the payments it would receive for aborted fetuses to be used in research and also considering changing the methods of abortion to ensure higher quality “product.” Since clever editing can make almost anything seem rather bad, it is a good general rule of critical thinking to look beyond such video.
In this case the unedited video is also available, thus allowing people to get the context of the remarks. There is, however, still reasonable general concerns about what happened off camera as well as the impact of crafting and shaping the context of the recorded conversation. That said, even the unedited video does present what could reasonably regarded as moral awfulness. To be specific, there is certainly something horrible in casually discussing fees for human remains over wine (I will discuss the ethics of fetal tissue research later).
The defenders of Planned Parenthood have pointed out that while the organization does receive fees to cover the costs associated with the fetal tissue (or human remains, if one prefers) it does not make a profit from this and it does not sell the tissue. As such, the charge that Planned Parenthood sells fetal tissue for a profit seems to be false. Interestingly, making a profit off something that is immoral strikes some as morally worse than doing something wrong that fails to make a profit (which is a reversal of the usual notion that making a profit is generally laudable).
It could be replied that this is a matter of mere semantics that misses the real point. The claim that the organization does not make a profit would seem to be a matter of saying that what it receives in income for fetal tissue does not exceed its claimed expenses for this process. What really matters, one might argue, is not whether it is rocking the free market with its tissue sales, but that it is engaged in selling what should not be sold. This leads to the second matter, which is whether or not Planned Parenthood is selling fetal tissue.
As with the matter of profit, it could be contended that the organization’s claim that it is receiving fees to cover expenses and is not selling fetal tissues is semantic trickery. To use an analogy, a drug dealer might claim that he is not selling drugs. Rather, he is receiving fees to cover his expenses for providing the drugs. To use another analogy, a slaver might claim that she is not selling human beings. Rather, she is receiving fees to cover her transportation and manacle expenses.
This argument has considerable appeal, but can be responded to. One plausible response is that there can be a real moral distinction between covering expenses and selling something. This is similar to the distinction between hiring a person and covering her expenses. To use an example, if I am being paid to move a person, then I have been hired to move her. But, if I help a friend move and she covers the cost of the gas I use in transporting her stuff, I have not been hired. There does seem to be a meaningful distinction here. If I agree to help a friend move and then give her a moving bill covering my expenses and my hourly pay for moving, then I seem to be doing something rather different than if I just asked her to cover the cost of gas.
To use a selling sort of example, if I pick up a pizza for the guys and they pay what the pizza cost me to get (minus my share), then I have not sold them a pizza. They have merely covered the cost of the pizza. If I charge them extra for the pizza (that is, beyond what it cost me), then I would seem to be doing something meaningfully different—I have sold them a pizza.
Returning to the Planned Parenthood situation, a similar argument can be advanced: the organization is not selling the fetal tissue, it is merely having its expenses covered. This does seem to matter morally. I suspect that one worry people have about tissue selling is that the selling would seem to provide an incentive to engage in morally problematic behavior to acquire more tissue to sell. To be specific, if the expense of providing the tissue for research is being covered, then there is no financial incentive to increase the amount of “product” via morally dubious means. After all, if one is merely “breaking even” there is no financial incentive to do more of that. But, if the tissue is being sold, then there would be a financial motive to get more “product” to sell—which would incentivize pushing abortions.
Going with the moving analogy, if I am selling moving services, then I want to sell as much as I can. I might even engage in dubious behavior to get more business. If I am just getting my gas covered, I have no financial incentive to engage in more moves. In fact, the hassle of moving would give me a disincentive to seek more moving opportunities.
This, obviously enough, might be regarded by some as merely more semantic trickery. Whether it is mere semantics or not does rest on whether or not there is a meaningful distinction between selling something and having the expenses for something covered, which seems to come down to one’s intuitions about the matter. Naturally, intuitions tend to vary greatly based on the specific issue—those who dislike Planned Parenthood will tend to think that there is no distinction in this case. Those same people are quite likely to “see” the distinction as meaningful in cases in which the entity receiving fees is one they like. Obviously, a comparable bias of intuitions applies to supporters of Planned Parenthood.
Even if one agrees that there is a moral distinction between selling and having one’s expenses covered, there are still at least two moral issues remaining. One is whether or not it is morally acceptable to provide fetal tissues for research (whether one is selling them or merely having expenses covered). The second is whether or not it is morally acceptable to engage in fetal tissue research. These issues will be covered in the next essay.